Axios Vitals: Patents = profits (Article 3)
Report: Hundreds of Patents on America’s Top Selling Drugs are Triggering Price Hikes and Blocking Competition
AbbVie faces hepatitis C patent challenge in India
Brief: AbbVie Hepatitis C Treatment Patents Challenged In India For Evergreening
I-MAK & Patients for Affordable Drugs File Amicus Brief with the US Supreme Court in support of RPX Corp in RPX Corp. v. Chanbond LLC
The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
With Only 15% of Diagnosed HCV Patients Receiving Treatment, the Non-Profit I-MAK Hopes to Shift the National Conversation on Drug Pricing
FDA publishes shame list of firms fighting generic competitors
FDA shames companies accused of blocking generic drug development
Trump is right: Abusive patents are the culprit behind high drug prices, but his plan doesn’t solve anything